Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA™) -: Review of the literature and six years of clinical experience

被引：20

作者：

Braun, M

Mathers, M

Bondarenko, B

Engelmann, U

机构：

[1] Univ Cologne, Dept Urol, DE-50924 Cologne, Germany

[2] Dept Urol, Remscheid, Germany

来源：

UROLOGIA INTERNATIONALIS | 2004年 / 72卷 / 01期

关键词：

transurethral needle ablation of the prostate; BPH; long-term results;

D O I：

10.1159/000075270

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Following FDA clearance and the establishment of Medicare coverage, transurethral needle ablation ( TUNA) has become an established and widely-adopted treatment method for BPH in the USA. Germany is lagging behind at present, though a change can also be recognized there. The lack of long-term data has often been criticized. This review presents an overview of clinical outcomes of TUNA, long-term results and patient selection criteria. Copyright (C) 2004 S. Karger AG, Basel.

引用

页码：32 / 39

页数：8

共 50 条

[41] A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia (vol 159, pg 1588, 1998)
Bruskewitz, R
JOURNAL OF UROLOGY, 1998, 160 (02): : 506 - 506
[42] Variations of transition zone volume and transition zone index after transurethral needle ablation for symptomatic benign prostatic hyperplasia
Fujimoto, K
Hosokawa, Y
Tomioka, A
Yamamoto, H
Tanaka, Y
Otani, T
Ozono, S
Hirao, Y
Hayashi, Y
INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (07) : 392 - 397
[43] NEW TECHNIQUES IN TRANSURETHRAL NEEDLE ABLATION LEADS TO PATIENT PREFERENCE OF PROSTIVA OVER MEDICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA
Smith, Craig
NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S60 - S60
[44] Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: A neurohistochemical study. Reply
不详
JOURNAL OF UROLOGY, 1998, 159 (01): : 210 - 210
[45] Economic evaluation of transurethral needle ablation (prostiva®) vs. transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH) in the spanish setting
Serrano, D.
Rodriguez, J.
Darba, J.
Restovic, G.
Fernandez, E.
VALUE IN HEALTH, 2006, 9 (06) : A386 - A386
[46] Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia
Plante, M. K.
Marks, L. S.
Anderson, R.
Amling, C.
Rukstalis, D.
Badlani, G.
Getlin, L.
Vang, E.
JOURNAL OF UROLOGY, 2007, 177 (03): : 1030 - 1035
[47] A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period - Editorial comment
McVary, K
JOURNAL OF UROLOGY, 2005, 173 (06): : 2093 - 2093
[48] A comparative study on transurethral vaporization of the prostate and transurethral resection of prostate for the treatment of benign prostatic hyperplasia - a single centre experience
Lu, Y.
Yeow, S.
Tan, Y. K.
BJU INTERNATIONAL, 2015, 115 : 2 - 3
[49] Transurethral needle ablation of the prostate:: An alternative minimally invasive therapeutic concept in the treatment of benign prostate hyperplasia
Braun, M
Zumbé, J
Korte, D
Solleder, G
Heidenreich, A
Engelmann, U
UROLOGIA INTERNATIONALIS, 1998, 61 (02) : 104 - 110
[50] TREATMENT OF BENIGN PROSTATIC HYPERPLASIA CAUSING COMPLETE URINARY RETENTION THROUGH LOCAL TRANSURETHRAL HYPERTHERMIA
RICHTER, S
NISSENKORN, I
ROTBARD, M
SLUTZKER, D
EUROPEAN UROLOGY, 1992, 22 (04) : 278 - 280

← 1 2 3 4 5 →